This new position paper analyses the current market segment situation and estimates its perspectives of evolution.
Thus, the following topics are covered:
- Regulatory framework
- Key stakeholders’ analysis (health authorities, HCPs, pharma companies)
- Scenario building and likely impacts
- Strategic options assessment
- Recommendations